Concepedia

Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial

Alain H. Litwin, Paula J. Lum, Lynn E. Taylor, Shruti H. Mehta, Judith I. Tsui, Judith Feinberg, Brianna L. Norton, Moonseong Heo, Julia H. Arnsten, Alison Karasz,

˜The œLancet. Gastroenterology & hepatology · 2022 · 70 citations · 19 references

DOI

Concepts

References

19

EASL recommendations on treatment of hepatitis C: Final update of the series☆

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2020 · 1.2K citations

, , +15

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

Yih‐Ing Hser, Andrew J. Saxon, David Huang et al. · Addiction · 2013 · 457 citations · Full text

, , +17

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

Soumitri Barua, Robert A. Greenwald, Jason Grebely et al. · Annals of Internal Medicine · 2015 · 397 citations · Full text

, , +17

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 292 citations · Full text

, , +14

<i>Vital Signs:</i>Newly Reported Acute and Chronic Hepatitis C Cases ― United States, 2009–2018

A. Blythe Ryerson, Sarah Schillie, Laurie K. Barker et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 162 citations · Full text

, , +10